share_log

赛生药业公布4.2万份购股权已获行使

Saisheng Pharmaceutical announced that 42,000 share options have been exercised

新浪港股 ·  Apr 2 19:58

Saisheng Pharmaceutical (06600) announced that on April 2, 2024, 42,000 share options granted under the company's initial public offering after-sales share option plan have been exercised in accordance with the rules of the initial public offering after-sales share option plan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment